“We saw positive growth in the OGM installed base this quarter, along with key advancements to our VIA software and the achievement of a significant milestone with the establishment of a Category I CPT code for OGM, which we believe will raise the awareness and utility of OGM,” commented Erik Holmlin, PhD, president and chief executive officer of Bionano. “We are continuing to focus on strengthening the company’s long-term growth profile and prioritizing efficiencies as we manage through a transition into a lower resource environment. We expect to continue to invest in opportunities where we see the greatest potential to increase global adoption and utilization of OGM.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Options Volatility and Implied Earnings Moves Today, August 07, 2024
- Options Volatility and Implied Earnings Moves This Week, August 05 – August 09, 2024
- Bionano Genomics announces participation at CGC 2024 meeting
- Bionano Genomics files to sell 35.035M share of common stock for holders
- Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference